Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors
US7968557B2 · kind B2 · utility
9Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2005 |
| Grant date | Jun 28, 2011 |
| Priority date | — |
| Expiry date | Sep 20, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the FAK, Abl, BCR-Abl, PDGF-R, c-Kit, NPM-ALK, Flt-3, JAK2 and c-Met kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.